Clinical significance of bcl-2 gene expression in human breast cancer tissues

By Kobayashi S.  

Breast Cancer Research and Treatment, Vol. 42, Iss. 2, 1997-01 ,pp. : 173-181

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced expression of bcl-2 following antisense oligonucleotide mediated growth factor deprivation

By Rubenstein Marvin   Chou Pauline   Mirochnik Yelena   Guinan Patrick  

Medical Oncology, Vol. 14, Iss. 1, 1997-03 ,pp. : 23-29

Humana Press, Inc

Access to resources Recommend Favorite

Bcl-2/bcl-xL Bispecific Antisense Treatment Sensitizes Breast Carcinoma Cells to Doxorubicin, Paclitaxel and Cyclophosphamide

By Simões-Wüst A.P.  

Breast Cancer Research and Treatment, Vol. 76, Iss. 2, 2002-11 ,pp. : 157-166

Springer Publishing Company

Access to resources Recommend Favorite

Expression of Bcl-2 Protein in Human Primary Breast Carcinomas and its Correlation with Multifocality, Histopathological Types and Prognosis

By Papadimitriou C.S.   Costopoulos J.S.   Christoforidou B.P.   Kotsianti A.J.   Karkavelas G.S.   Hytiroglou P.M.   Koufogiannis D.J.   Nenopoulou H.E.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1275-1280

Elsevier

Access to resources Recommend Favorite

Side-effects of resveratrol in HepG2 cells: Reduced pten and increased bcl-xl mRNA expression

By              

Molecular Medicine Reports, Vol. 6, Iss. 6, 2012-01 ,pp. : 1367-1370

Spandidos Publications

Access to resources Recommend Favorite